Drugs affecting HbA1c levels

Glycated hemoglobin (HbA1c) is an important indicator of glycemic control in diabetes mellitus, based on which important diagnostic and therapeutic decisions are routinely made. However, there are several situations in which the level of HbA1c may not faithfully reflect the glycemic control in a given patient. Important among these is the use of certain non-diabetic medications, which can affect the HbA1c levels in different ways. This review focuses on the non-diabetic medications which can inappropriately raise or lower the HbA1c levels, and the postulated mechanisms for the same.

[1]  P. Polgreen,et al.  Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  D. Giugliano.  Increased glycosylated haemoglobin A1 in opiate addicts: Evidence for a hyperglycaemic effect of morphine , 1982, Diabetologia.

[3]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[4]  Z. Bloomgarden,et al.  Review of hemoglobin A1c in the management of diabetes , 2009, Journal of diabetes.

[5]  J. Wetzels,et al.  Decreased HbA1c Levels Due to Sulfonamide-Induced Hemolysis in Two IDDM Patients , 1996, Diabetes Care.

[6]  M. S. Kirkman,et al.  Response to Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 , 2011, Diabetes Care.

[7]  Charles M Peterson,et al.  Tests of glycemia in diabetes. , 1995, Diabetes care.

[8]  M. Robertson.  Artificially low HbA1c associated with treatment with ribavirin , 2008, BMJ : British Medical Journal.

[9]  J. Gross,et al.  The effect of aspirin and vitamins C and E on HbA1c assays. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[10]  V. Mohan,et al.  Unexpectedly low HbA1c levels in two diabetes patients following dapsone use , 2012, Indian journal of endocrinology and metabolism.

[11]  D. Raccah,et al.  Interference of dapsone in HbA1c monitoring of a diabetic patient with polychondritis. , 2002, Diabetes & metabolism.

[12]  C. Vigouroux,et al.  Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. , 2006, AIDS research and human retroviruses.

[13]  J. Philippé,et al.  Spurious Glycohemoglobin Values Associated With Hydroxyurea treatment , 1997, Diabetes Care.

[14]  E. Kilpatrick,et al.  The Effect of Iron and Erythropoietin Treatment on the A1C of Patients With Diabetes and Chronic Kidney Disease , 2010, Diabetes Care.

[15]  H. Rodbard,et al.  Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[16]  O. Blumenfeld,et al.  Studies of an unusual hemoglobin in patients with diabetes mellitus. , 1969, Biochemical and biophysical research communications.

[17]  A. Rubenstein,et al.  HÆMOGLOBIN A1: AN INDICATOR OF THE METABOLIC CONTROL OF DIABETIC PATIENTS , 1977, The Lancet.

[18]  F. Ovalle,et al.  Artificially low hemoglobin A1c caused by use of dapsone. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[19]  J. Gross,et al.  Lack of interference of aspirin in HbA1c measured by ion-exchange HPLC in type 2 diabetic patients: a randomized, double-blind, placebo-controlled study. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[20]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[21]  C. Kesson,et al.  Drug-induced haemolysis and fast haemoglobin A1 in diabetes mellitus. , 1979, British medical journal.